Lenvatinib as first-line treatment for advanced thyroid cancer: long progression-free survival
Simone De Leo, Marta Di Stefano, Luca Persani, Laura Fugazzola, Carla Colombo
Topics & Concepts
MedicineLenvatinibDiscontinuationInternal medicineAdverse effectRefractory (planetary science)Progression-free survivalAnorexiaProgressive diseaseCohortThyroid cancerCancerOncologyDiseaseOverall survivalAstrobiologyPhysicsThyroid Cancer Diagnosis and TreatmentThyroid Disorders and TreatmentsRenal cell carcinoma treatment